Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. APIs - An Introduction

4. Industry
     4.1 Current and Future Market Analysis to 2018

5. Countries’ Comparative Analysis: API Manufacturing
     5.1 Labor Cost and Productivity
     5.2 Price Structure
     5.3 Investment Cost in Plant Set-up

6. Key Geographical Markets
     6.1 Americas
            6.1.1 Current and Future Market
     6.2 Asia
            6.2.1 Current and Future Market
     6.3 Europe
            6.3.1 Current and Future Market
     6.4 Others

7. Major Countries and their Regulatory Scenario
     7.1 United States
            7.1.1 Current and Future Market
            7.1.2 Future Opportunity Assessment
     7.2 Japan
            7.2.1 Current and Future Market
            7.2.2 Future Opportunity Assessment
     7.3 Italy
            7.3.1 Current and Future Market
            7.3.2 Future Opportunity Assessment
     7.4 China
            7.4.1 Current and Future Market
            7.4.2 Future Opportunity Assessment
     7.5 India
            7.5.1 Current and Future Market
            7.5.2 Future Opportunity Assessment
     7.6 South Korea
            7.6.1 Current and Future Market
            7.6.2 Future Opportunity Assessment
     7.7 Others

8. Analysis by Therapeutic Segments
     8.1 Central Nervous System Disorders
     8.2 Cardiovascular Diseases
     8.3 Diabetes
     8.4 Respiratory Disorders
     8.5 Oncology

9. Trends & Challenges

10. Competitive Landscape
     10.1 BASF SE
     10.2 Kyowa Hakko Kirin
     10.3 North China Pharmaceutical Group Corporation
     10.4 Teva Active Pharmaceutical Ingredients
     10.5 Northeast Pharmaceutical Group
     10.6 Lonza
     10.7 Dr Reddy’s Laboratories
     10.8 Zhejiang Hisun Pharmaceutical Co. Ltd.
     10.9 Fabbrica Italiana Sintetici
     10.10 Aurobindo Pharma Limited
     10.11 Pfizer CentreSource
     10.12 Divis Laboratories Limited
     10.13 Cambrex Corporation
     10.14 Royal DSM
     10.15 Boehringer Ingelheim GmbH